Psychologist Irving Kirsh aims to “explode the myth” of Prozac and its ilk, arguing that there’s little evidence that they actually work for most patients.
The following article is a sample from DISCOVER’s special Brain issue, available only on newsstands through June 28.
Depression is a chemical imbalance, most people think. Researchers, drug manufacturers, and even the Food and Drug Administration assert that antidepressants work by “normalizing” levels of brain neurotransmitters—chemical messengers such as serotonin. And yet hard science supporting this idea is quite poor, says Irving Kirsch, professor of psychology at the University of Hull in the U.K. An expert on the placebo effect, Kirsch has unearthed evidence that antidepressants do not correct brain chemistry gone awry. More important, the drugs are not much more effective against depression than are sugar pills, he says. To support these controversial claims, Kirsch conducted a meta-analysis, digging up data from unpublished clinical trials. When all the evidence is weighed together, Prozac, Paxil, and other such popular pills seem to be at best weakly effective against depression—an argument Kirsch presses in his new book, The Emperor’s New Drugs. Some other research backs up his claims. A study published this winter in the Journal of the American Medical Association found that psychoactive drugs are no better than placebos for people suffering from mild to moderate depression. link to continue reading
Source: Discover
